Do you recommend homogenous or inhomogenous dose distribution for postoperative SRS/FSRT for a resected brain metastasis?   

There are data for improved outcomes for inhomogeneous dose distribution in patients with intact brain tumors (Lucia et al, Radiother Oncol 2018), but I am unaware of data for postoperative patients. Does it matter if there is residual disease on post-operative imaging?



Answer from: Radiation Oncologist at Academic Institution